Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

22
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
22
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

199
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
199
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

69
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
69
Cancer Survival Analysis01:21

Cancer Survival Analysis

303
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
303
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

504
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
504
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

90
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
90

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive risk assessment and evaluation of the impact of amino acid preparations on peripheral line-associated bloodstream infection: A single-center retrospective observational study using propensity score matching.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

Effect of Oral and Gut Microbiota, Dietary Intake, and Genetic Polymorphisms on Older Adults with Metabolic Dysfunction Associated Fatty Liver Disease.

Sage open aging·2026
Same author

Alteration of small intestinal microbiota in diet-induced steatohepatitis mice.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2026
Same author

Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study.

Journal of clinical medicine·2026
Same author

Very high acute pacing thresholds during atrial leadless pacemaker implantation: Feasibility of a current-of-injury-guided release strategy.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2026
Same author

An Epidemiological Study on the Relationship between Gastric Mucosal Atrophy, Exhaled Hydrogen Concentration, and Gut Microbiota.

Digestion·2026
Same journal

Single nucleus RNA profiling reveals potential therapeutic vulnerabilities in sinonasal carcinomas.

NPJ precision oncology·2026
Same journal

Integrated multiclass driver ctDNA profiling enables MPNST detection and monitoring in NF1 patients.

NPJ precision oncology·2026
Same journal

Proliferation- and cytotoxic immune signatures identify chemotherapy-responsive bladder tumors in a molecular subtype dependent manner.

NPJ precision oncology·2026
Same journal

From tumor regression grading to interpretable endpoints in neoadjuvant oncology.

NPJ precision oncology·2026
Same journal

Mutation enrichment in targeted panels flags immunotherapy-responsive POLE-driven hypermutated microsatellite-stable colorectal cancers.

NPJ precision oncology·2026
Same journal

Neoadjuvant Danburstotug (IMC-001) therapy in gastric, esophageal, and hepatocellular carcinoma: the NeoChance phase II study.

NPJ precision oncology·2026
See all related articles

Related Experiment Video

Updated: May 13, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K

Predicting survival in prospective clinical trials using weakly-supervised QSP.

Matthew West1,2, Kenta Yoshida2, Jiajie Yu3

  • 1Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

NPJ Precision Oncology
|April 14, 2025
PubMed
Summary
This summary is machine-generated.

Quantitative systems pharmacology (QSP) models now predict patient survival in cancer immunity by linking virtual patients to clinical data. This approach enhances anti-cancer drug development by accurately forecasting treatment outcomes.

More Related Videos

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Related Experiment Videos

Last Updated: May 13, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.0K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

Area of Science:

  • Computational biology
  • Translational oncology
  • Pharmacometrics

Background:

  • Quantitative systems pharmacology (QSP) models offer mechanistic insights into cancer immunity and drug effects.
  • Current QSP models lack the ability to mechanistically predict patient survival, limiting their use in anti-cancer drug development.

Purpose of the Study:

  • To link virtual patients from a QSP model to real clinical trial patients to enable mechanistic prediction of survival outcomes.
  • To develop a novel approach for anti-cancer drug development by integrating QSP models with clinical data.

Main Methods:

  • Linked virtual patients from a QSP model to real patients from atezolizumab trials in non-small cell lung cancer.
  • Utilized tumor-based linkage to capture survival outcomes.
  • Treated linked survival and censoring as weak supervision labels to train survival models using QSP covariates only.
  • Predicted survival for treatments not included in the training data.

Main Results:

  • Tumor-based linkage effectively captured survival outcomes in non-small cell lung cancer.
  • The developed survival models accurately predicted survival outcomes using only QSP covariates.
  • Accurately estimated survival hazard ratios (HR) for chemotherapy monotherapy and atezolizumab plus chemotherapy combination.
  • Predicted HR of 0.70 (95% PI 0.55-0.86) closely matched the observed HR of 0.79 (95% PI 0.64-0.98) from the IMpower130 trial.

Conclusions:

  • Linking QSP models with clinical trial data enables mechanistic prediction of patient survival.
  • This approach enhances the utility of QSP models in anti-cancer drug development.
  • The method shows potential for predicting survival for novel treatment combinations.